Pharma Reviews: Aurobindo, Cipla, Biocon top picks; see FDA plan to be double edged sword: Citi

Indian pharma companies were under pressure in the last one year due regulatory issues. Constant warning letters from United States Food & Drug ...
Read more: Aurobindo, Cipla, Biocon top picks; see FDA plan to be double edged sword: Citi